C84.47
Peripheral T-cell lymphoma, not elsewhere classified, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma of the spleen is a rare type of non-Hodgkin lymphoma that originates in T lymphocytes, a type of white blood cell vital for immune response. Classified under ICD-10 code C84.47, this lymphoma primarily involves the spleen, an organ that filters blood and helps fight infections. This condition is characterized by abnormal growth of T-cells in the spleen, leading to swelling, symptoms related to immune dysfunction, and potentially affecting other organs or lymph nodes as the disease progresses.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect T-cell development Previous exposure to certain chemicals or radiation Immunodeficiency conditions that impair immune regulation Infections associated with immune activation, such as certain viruses Unknown causes, with many cases arising sporadically
Key Symptoms: Splenomegaly (enlarged spleen), which can cause a feeling of fullness or discomfort in the abdomen Unintentional weight loss Fever and night sweats Fatigue or weakness Swollen lymph nodes in other areas Easy bruising or bleeding, due to blood cell involvement Frequent infections resulting from immune suppression
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination, laboratory tests, and imaging studies. A definitive diagnosis usually requires a biopsy of the spleen or affected lymph nodes to examine tissue under a microscope. Additional tests may include blood tests to evaluate blood cell counts, flow cytometry to analyze cancer cell types, and imaging techniques such as CT or PET scans to assess the extent of disease spread. Molecular studies may also be performed to identify specific genetic alterations.
Treatment Protocols: Treatment options depend on the stage and overall health of the patient. Common approaches include chemotherapy regimens aimed at destroying cancerous cells, targeted therapies that focus on specific molecular features of the lymphoma, radiation therapy in localized cases, and potentially splenectomy (surgical removal of the spleen). Supportive care to manage symptoms and prevent complications, such as infections, is also crucial. Participation in clinical trials may be considered for emerging therapies or novel treatment combinations.
Clinical Advice & FAQs
Billing Guidance
Is C84.47 a billable ICD-10 code?
Yes, C84.47 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.47?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference